University of Kentucky

UKnowledge
Nursing Faculty Publications

College of Nursing

1-2014

Examination of the Potential Association of Stress with Morbidity
and Mortality Outcomes in Patient with Heart Failure
Abdullah S. Alhurani
University of Kentucky, abdullah.alhurani7@uky.edu

Rebecca Dekker
University of Kentucky, rebecca.dekker@uky.edu

Elizabeth Tovar
University of Kentucky, elizabeth.gressle@uky.edu

Alison Bailey
University of Kentucky

Terry A. Lennie
University of Kentucky, terry.lennie@uky.edu

See next page for additional authors
Follow this and additional works at: https://uknowledge.uky.edu/nursing_facpub
Part of the Nursing Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Alhurani, Abdullah S.; Dekker, Rebecca; Tovar, Elizabeth; Bailey, Alison; Lennie, Terry A.; Randall, David C.;
and Moser, Debra K., "Examination of the Potential Association of Stress with Morbidity and Mortality
Outcomes in Patient with Heart Failure" (2014). Nursing Faculty Publications. 19.
https://uknowledge.uky.edu/nursing_facpub/19

This Article is brought to you for free and open access by the College of Nursing at UKnowledge. It has been
accepted for inclusion in Nursing Faculty Publications by an authorized administrator of UKnowledge. For more
information, please contact UKnowledge@lsv.uky.edu.

Examination of the Potential Association of Stress with Morbidity and Mortality
Outcomes in Patient with Heart Failure
Digital Object Identifier (DOI)
http://dx.doi.org/10.1177/2050312114552093

Notes/Citation Information
Published in SAGE Open Medicine, v. 2, article 2050312114552093, p. 1-9.
© The Author(s) 2014.
Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which
permits non-commercial use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access page
(http://www.uk.sagepub.com/aboutus/openaccess.htm).

Authors
Abdullah S. Alhurani, Rebecca Dekker, Elizabeth Tovar, Alison Bailey, Terry A. Lennie, David C. Randall, and
Debra K. Moser

This article is available at UKnowledge: https://uknowledge.uky.edu/nursing_facpub/19

552093
research-article2014

SMO0010.1177/2050312114552093SAGE Open MedicineAlhurani et al.

SAGE Open Medicine

Original Article

Examination of the potential association
of stress with morbidity and mortality
outcomes in patient with heart failure

SAGE Open Medicine
2: 2050312114552093
© The Author(s) 2014
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2050312114552093
smo.sagepub.com

Abdullah S Alhurani1,2, Rebecca Dekker1, Elizabeth Tovar1, Alison
Bailey1, Terry A Lennie1, David C Randall1 and Debra K Moser1

Abstract
Objectives: The high mortality and morbidity rates associated with heart failure are still not well explained. A few
psychosocial factors have been studied and explain some of this risk, but other factors, like stress, remain largely unexplored
in heart failure. This study aimed to (1) examine the association of stress with 6-month cardiac event-free survival, (2)
examine the relationship of stress with salivary cortisol, and (3) examine the association of salivary cortisol level with
6-month cardiac event-free survival.
Method: A total of 81 heart failure patients participated. Stress was measured using the brief Perceived Stress Scale. Cortisol
was measured from unstimulated whole expectorated saliva. Cox regression analyses were used to determine whether
stress predicted event-free survival, and if salivary cortisol predicted event-free survival. Linear and multiple regressions
were used to determine the association of stress with salivary cortisol.
Results: Stress was not a significant predictor of event-free survival in heart failure (heart rate = 1.06; 95% confidence
interval = 0.95–1.81; p = 0.32). Salivary cortisol was a significant predictor of event-free survival in the unadjusted model (heart
rate = 2.30; 95% confidence interval = 0.99–5.927; p = 0.05), but not in the adjusted model. Stress (β 1.06; 95% confidence
interval = 0.95–1.18; p = 0.32) was not a significant predictor of salivary cortisol level.
Conclusion: Stress is a complex phenomenon, and our measure of stress may not have captured it well. Alternatively, the
physical stressors acting in heart failure produce levels of neurohormonal activation that mask the effects of psychosocial
stressors or an indirect association of stress with outcomes that is mediated through another construct. Future studies are
needed to investigate stress in patients with heart failure to provide definitive answers.
Keywords
Stress, heart failure, cortisol, event-free survival, health outcomes
Date received: 22 April 2014; accepted: 26 August 2014

Introduction
Worldwide, heart failure (HF) is considered a major public
health problem.1–9 Although there have been significant therapeutic advances in pharmacological and surgical treatment
of HF, hospital admission and readmission rates are
extremely high for exacerbations of HF, and the 1-year mortality rate of HF patients with progressive symptoms still
approaches 40%.10–13 The high mortality and morbidity rates
associated with HF are not completely explained by biological mechanisms,14 as psychological factors are important
predictors of morbidity and mortality in HF. One psychological factor that might contribute to morbidity and mortality in patients with HF is stress.14–20

Stress is the condition that occurs when environmental
demands exceed an individual’s ability to adapt to the
demands.21 A prerequisite for stress to occur is the individual’s perception that stressors are perceived as a persistent
threat to their physical and/or psychological health or
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well-being.22 Stress is an umbrella term that summarizes the
effects of psychological and environmental stressors on an
individual’s physical and mental health.23,24 HF is commonly
perceived by patients as a very stressful experience both
physically and psychologically.16,25
There is limited information about the relationship
between stress and HF. However, in patients with cardiovascular disease, psychological stress was associated with multiple adverse effects on patient health outcomes.26–30 In
patients with cardiovascular disease, psychological stress
has been associated with decreased coronary artery blood
supply, greater severity of cardiac disease, worse prognosis,
and poorer cardiac function.31–35 Stress is also associated
with multiple psychological factors such as anxiety and
depression that have negative effects on health outcomes like
mortality and morbidity in HF and cardiac disease.15,36–38
Given the likelihood that HF is a substantial stressor for
many patients, the examination of the role of stress on health
outcomes in patients with HF is important. The specific aims
of this study were to (1) examine the association of stress
with 6-month cardiac event-free survival, controlling for
anxiety, depression, and New York Heart Association
(NYHA) functional class; (2) examine the relationship of
stress with salivary cortisol; and (3) examine the association
of salivary cortisol level with 6-month cardiac event-free
survival, controlling for age, gender, and NYHA class. We
hypothesized that stress and salivary cortisol are predictors
of event-free survival in HF patients. In addition, we hypothesized that stress is a predictor of salivary cortisol level in
HF patients.

Method

(2) 21 years or older, (3) able to read and speak English, and
(4) no obvious cognitive impairment. Patients with HF with
either preserved or non-preserved ejection fraction were
included. Patients were excluded from the study for the following reasons: (1) co-existing terminal illness likely to be
fatal within the next 6 months; (2) presence of a left ventricular assist device, continuous inotropic infusion, or hospice
care; (3) active suicidality (defined as choosing option 2 or 3
on item 9 of the Beck Depression Inventory-II); (4) history
of the death of a spouse or child within the past month; (5)
history of psychotic illness or bipolar illness; (6) current
alcohol dependence or other substance abuse; and (7) newonset HF.

Measures
Stress
Stress was measured using the brief version of the Perceived
Stress Scale.39 The brief version consists of a 4-item scale
which has been demonstrated to be reliable and valid.39 The
4 items are as follows: (1) How often have you felt that you
were unable to control the important things in your life? (2)
How often have you felt confident about your ability to handle your personal problems? (3) How often have you felt that
things were going your way? (4) How often have you felt
difficulties were piling up so high that you could not overcome them? Each item is rated by respondents on a scale
ranging from 0 (never) to 5 (very often). Higher scores indicate greater levels of stress. In this study, the Cronbach’s
alpha of the 4-items perceived stress scale was 0.70.

Event-free survival

Design, sample, and setting
A prospective design was used in which patients were followed for 6 months to determine occurrence of 6-month cardiac event-free survival, defined as time to the combined
endpoint of cardiac rehospitalization or all-cause death.
This study was a part of the Heart Outcomes Prevention
Evaluation (HOPE) study at the University of Kentucky that
investigated depression among hospitalized patients with
HF. The parent study and the current study were approved
by the Institutional Review Board at the University of
Kentucky. The sample consisted of 81 patients with confirmed HF who were hospitalized for cardiac reasons (i.e.
hospitalization for HF, acute coronary syndrome, dysrhythmias) at the University of Kentucky Chandler Medical
Center or GoodSamaritanHospital, which are located in
Lexington, Kentucky.
Patients with a diagnosis of chronic HF confirmed by
echocardiogram and cardiologist were eligible for participation in the study if they met the following criteria: (1) admitted to the hospital with a primary or secondary diagnosis of
exacerbation of chronic HF or any other cardiac diagnosis,

Event-free survival was defined as the combined endpoint of
cardiac rehospitalization or all-cause death. Hospitalization data
were determined through a combination of patient and family
interviews and a review of medical records. Hospitalizations
were verified by trained research assistants who reviewed medical records and clinic notes on a weekly basis. Given the possibility that patients could have been hospitalized at different
facilities other than the three sites involved in the study, trained
research assistants carefully questioned the patients or family
members by phone to determine whether hospitalization had
occurred.
All-cause mortality was determined by interview with the
patient’s family, medical record review, and review of county
death records. At enrollment, the patient was asked for contact information of a close friend or family member in case
the patient could not be contacted. At follow-up, if a patient
could not be reached by phone, hospital records were
searched. When information regarding the patient was not
available, family members or friends were contacted. If these
contacts could not be reached, county death records were
used to determine patient death.
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Salivary cortisol
Cortisol was measured from saliva obtained from patients at
baseline through an unstimulated whole expectorated saliva
collection protocol. Patients were provided a 20-mL vial containing freeze dried protease inhibitor. Patients were asked to
swallow once and begin expectorating approximately every
20–30 s until 5 mL is collected. The specimen was kept on ice
until returned to the lab. Salivary sample was obtained in the
morning (9:00 a.m.) on the day of enrollment. The salivary
samples were stored in a −80°C freezer until they were analyzed using a commercially available enzyme immunoassay
kit designed for cortisol quantification in saliva (Salimetrics
LLC, State College, PA, USA). This assay has a sensitivity of
<0.007 µg/dL and is strongly correlated with serum cortisol
measurement (0.91). Salivary cortisol is considered a more
accurate and reliable measure for the clinical assessment of
adrenocortical function than serum cortisol.40,41

Depressive symptoms
The Patient Health Questionnaire–9 (PHQ-9)42,43 was used
to measure depressive symptoms. The PHQ-9 is a 9-item,
self-reported measure of depressive symptom severity.
Patients respond to each item on a Likert scale ranging from
0 (not at all) to 3 (nearly every day). The total summary score
can range from 0 to 27; a higher score reflects more severe
depressive symptoms. Good internal consistency, stability,
construct, and concurrent validity of the PHQ-9 have been
supported.42,44 The standard published cut point of 10 was
selected in this study for PHQ-9 to identify those in the sample who had moderate to severe depressive symptoms.28 This
cut point was reported to have 88% sensitivity and 88%
specificity for diagnosing major depression.44,45 In this study,
the Cronbach’s alpha of the PHQ-9 scale was 0.73.

NYHA class. The NYHA class indicates the level of functional impairment reported by patients as a result of symptoms
and was rated by trained research nurses. These variables were
selected because of their effects on the outcome variable as
suggested in the literature.45,49

Procedure
Protocols for this study were approved by institutional
review board of The University of Kentucky. All procedures
were in accordance with institutional guidelines for research
using human subjects. Hospitalized patients were identified
by clinicians and referred to research staff. The research staff
determined the patient’s eligibility. The study was thoroughly explained to each patient, and signed consent was
obtained after answering any questions about the study. The
research staff met with the patient to administer study questionnaires via the web-based SurveyMonkey. The questionnaires took approximately 20 min to complete. A paper copy
also was offered to the patient if they did not feel comfortable with the web-based survey.
As a part of HOPE study, patient were contacted by phone
to complete the follow-up questionnaire at 2 weeks, 3 months,
and 6 months from hospital discharge. At each telephone
contact, the research staff asked the patient whether he or she
has been hospitalized or visited the emergency unit. At the
end of the study period and intermittently thereafter, hospital
records were reviewed to confirm deaths, re-hospitalizations,
or emergency department visits.
Salivary samples were obtained for cortisol measurement
in the morning at baseline at the time of questionnaires completion. All saliva samples were stored at −80°C until analysis of samples at the University of Kentucky Dentistry
Research laboratory.

Anxiety

Statistical analysis

The Brief Symptom Inventory (BSI) anxiety subscale was
used to measure anxiety.46,47 The subscale consists of six
questions, each of which is scored by patients using a scale
that ranges from 0 (not at all) to 4 (extremely). The total score
is calculated as the mean of the 6-item scores. Thus, the possible range of scores for the anxiety scale is 0–4, with higher
scores indicative of higher levels of anxiety. The BSI has
demonstrated internal consistency, stability, construct, and
concurrent validity in other studies.46,47 In this study, the
Cronbach’s alpha of the anxiety scale was 0.77. A standard
published mean score of 0.35 was used to identify those in the
sample who were anxious and those who were not anxious.48

Data were analyzed using SPSS software, version 20.0
(SPSS Inc., Chicago, IL, USA). Descriptive statistics, including mean, standard deviation, and frequency distribution,
were used to describe sample characteristics. To test Specific
Aim 1, unadjusted, followed by adjusted, Cox regression
analyses were used to determine whether stress independently predicted event-free survival. The following covariates were considered in the adjusted analysis and entered
hierarchically: age, gender, NYHA class, and anxiety and
depression. Demographic and clinical variables were entered
first into the model. Then, anxiety and depressive symptoms
were entered. Finally, stress as a continuous level variable
was entered into the model. The same analysis was conducted using categorical level variables with the mean and
median as cut-points.
To test Specific Aim 2, linear and multiple regressions
were used to determine the association of stress with salivary
cortisol. This analysis included a sample of 70 patients

Demographic and clinical variables
Data on demographic variables and clinical characteristics
were collected by reviewing medical records and interviewing
patients. These variables included age, gender, ethnicity, and
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because not all of the patients were able to provide a salivary
sample. Two groups, low and high salivary cortisol level,
were created based on the median of salivary cortisol level
and used in this analysis. This analysis was conducted using
both categorical and continuous level variables of salivary
cortisol. To test Specific Aim 3 using the same sample size
(n = 70), unadjusted Cox regression analysis was conducted
to determine whether cortisol predicted event-free survival.
Then, a hierarchal Cox regression analysis was used controlling to the following covariates: age, gender, and NYHA
class. Again, this analysis was conducted using both categorical and continuous level variables of salivary cortisol. The
demographic and clinical variables were entered first and
cortisol was entered second. The assumptions of all Cox
regressions, and linear and multiple regressions, were tested
for violations and none were noted. A p-value of ≤0.05 was
considered statistically significant.

Results
Demographic and clinical characteristics of patients (N = 81)
are summarized in Table 1. The average stress score in this
sample was 9.47 ± 3.86, with a range of 4–20. No cut point
has been defined for this instrument to date; however, the
mean stress score in this study was higher than has been
reported in other studies for the same scale.39,50,51 For example, in a study of college students, the mean score was
5.6 ± 3.6,39 and in a study of Chinese patients with cardiac
conditions, the mean was 6.0 ± 2.0.51
The average anxiety score was 0.58 ± 0.68. Using the
published BSI average in the general population of 0.35,48
46.7% scored as anxious. The average depressive symptoms
score was 8.00 ± 4.87, and using the standard published
PHQ-9 cut point 10,28 29.6% of the sample was suffering
from depressive symptoms. The average salivary cortisol
level was 0.32 ± 0.23 µg/dL.

Specific aim 1: stress and the prediction of eventfree survival
A total of 28 (35%) patients had an event. Six (7.4%) died
and 22 (27.2%) were hospitalized for cardiac reasons during
the study. In the unadjusted model, stress (heart rate
(HR) = 1.04; 95% confidence interval (CI) = 0.95–1.13;
p = 0.46) was not a predictor of event-free survival. In the
adjusted model with age, gender, NYHA, anxiety, and
depressive symptoms as covariates, the overall model
(χ2 = 3.14, df = 6; p = 0.79) was not significant (Table 2).
None of the variables were significant in any step of the
hierarchal Cox regression. In the final model, stress
(HR = 1.06; 95% CI = 0.95–1.81; p = 0.32) was not a predictor of event-free survival. An additional exploratory Cox
regression analysis was conducted using stress as a categorical variable. The results were similar in that stress did not
predict the outcome.

Table 1. Sample characteristics (N = 81).
Characteristic

N (%) or mean ± SD

Age, years
Anxiety score
Depressive symptoms score
Stress score
Cortisol level, µg/dL (N = 70)
Gender
Male
Female
Ethnicity
Caucasian
African American
NYHA class
I/II
III/IV
Stress
Not stressed
Stressed
Anxiety
Not anxious
Anxious
Depression
None/mild depression
Moderate/severe

58.07 ± 13.07
0.58 ± 0.63
8.00 ± 4.87
9.47 ± 3.86
0.32 ± 0.23
43 (53.1)
46 (46.9)
62 (76.5)
19 (23.5)
39 (48.1)
42 (51.9)
42 (51.9)
39 (48.1)
44 (54.3)
37 (45.7)
57 (70.4)
24 (29.6)

SD: standard deviation; NYHA: New York Heart Association.

Table 2. Adjusted Cox proportional hazards regression model
of variables associated with cardiac event-free survival (stress
model).
Predictor variables

Hazard
ratio

Age
1.01
Female gender
0.92
NYHA class III/IV compared to I/II 0.70
Anxiety
0.70
Depression
1.07
Stress
1.06
Final overall model (χ2 = 3.14, df = 6; p = 0.79)

95% CI

p

0.98–1.04
0.43–1.98
0.29–1.47
0.30–1.52
0.97–1.18
0.95–1.18

0.57
0.84
0.30
0.68
0.19
0.32

CI: confidence interval; NYHA: New York Heart Association.

Specific aim 2: association of stress and salivary
cortisol
The linear and multiple regressions (n = 70) showed that
stress level was not a significant predictor of salivary cortisol
(Tables 3 and 4). In addition, none of the covariate variables
(age, gender, NYHA, and anxiety) in the multiple regression
analysis was a significant predictor of salivary cortisol except
age (HR = 0.26; 95% CI = 0.00–0.01; p = 0.04) (Table 4). An
additional exploratory Cox regression analysis was conducted using salivary cortisol as a categorical variable. The
results were similar in that salivary cortisol did not predict the
outcome.
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Table 3. Linear regression of stress level associated with salivary
cortisol of patients with heart failure.
Predictor
variable

β

95% CI

p

Stress
−0.06
−0.02 to 0.01
0.60
Overall model (adjusted R2 = −0.01, F = 0.28; p = 0.60)
β: adjusted regression slope coefficient; CI: confidence interval.

Table 4. Multiple linear regression of variables associated with
salivary cortisol of patients with heart failure.
Predictor variables

β

95% CI

p

Age
0.26
0.00 to 0.01
0.04
Female gender
−0.20
−0.25 to 0.03
0.11
NYHA class III/IV
0.15
−0.07 to 0.23
0.27
compared to I/II
Anxiety
−0.002
−0.12 to 0.12
0.99
Stress
−0.09
−0.03 to 0.01
0.55
Overall model (adjusted R2 = 0.056, F = 1.769; p = 0.133)
β: adjusted regression slope coefficient; CI: confidence interval; NYHA:
New York Heart Association.

Table 5. Unadjusted Cox proportional hazards regression
model of variables associated with cardiac event-free survival
(salivary cortisol model).
Predictor variables

Hazard
ratio

High cortisol level
2.30
compared to low level
Overall model (χ2 = 4.00, df = 1; p = 0.45)

95% CI

p

0.99–5.927

0.05

CI: confidence interval.

Specific aim 3: salivary cortisol and the prediction
of event-free survival
In the Cox regression analysis, where salivary cortisol level
was the independent variable (n = 70), 24 patients (34.3%)
had an event. In all, 4 (5.7%) of the participants died and 20
(28.6%) were hospitalized during the study. In an unadjusted model, salivary cortisol (HR = 2.30; 95% CI = 0.99–
5.93; p = 0.05) was a significant predictor of event-free
survival (Table 5 and Figure 1). However, in the adjusted
model with age, gender, and NYHA as covariates, the overall model (χ2 = 5.34, df = 4; p = 0.25) was not significant.
None of the variables were significant in any step of the
hierarchal Cox regression. In the final model, higher level of
salivary cortisol (HR = 2.03; 95% CI = 0.84–4.93; p = 0.12)
was not a predictor of event-free survival (Table 6). An
additional exploratory Cox regression analysis was conducted using salivary cortisol as a continuous variable. The
results for both adjusted and unadjusted models were not
significant.

Discussion
Psychosocial factors such as depression, anxiety, and lack of
social support are associated with poor health outcomes in
adults with HF.11,52 Clinicians and researchers commonly
suggest that patients with HF have high levels of stress and
that these levels of stress might contribute to poor outcomes.53 To the best of our knowledge, this is the first study
to investigate stress and associated cortisol level as predictors of cardiac morbidity and all-cause mortality in patients
with HF. Based on our literature review and the scientific
background related to HF, stress, and morbidity and mortality, we hypothesized that stress and salivary cortisol would
be a predictor of 6-month cardiac event-free survival. We
also hypothesized a significant association between stress
level and salivary cortisol level. None of these hypotheses
were supported expect that salivary cortisol was a significant
predictor of 6-month cardiac event-free survival in the unadjusted model only. Our findings suggest that stress level was
not associated with cardiac rehospitalization and mortality
among HF patients.
Our hypotheses were based on the physiological mechanisms whereby stress may affect the progression of cardiovascular disease in general. Stress is thought to involve the
hypothalamic–pituitary–adrenocortical (HPA). Much of the
research on animals and humans suggests that psychological
factors can influence the HPA axis, which controls the release
of cortisol, a glucocorticoid that is secreted by the adrenal
cortex to support and control physiological functions.54 Over
the past decades, many investigators have concluded that
physical and psychological stressors are capable of activating the HPA axis and increasing cortisol level in the blood
stream.54 Through cortisol, the HPA supports physiological
functions and regulates other systems. However, prolonged
elevation in cortisol due to frequent stress is associated with
many negative biological effects such as suppression of the
immune system, damage to hippocampal neurons, and development and progression of chronic diseases like diabetes and
hypertension.34,55 In HF, cortisol may contribute to the progression of cardiac damage by acting as a mineralocorticoid
receptor (MR) agonist in the cardiac muscle where cortisol
mimics the physiological and pathophysiological effects of
aldosterone.56–59 Given these data, it is crucial to determine
whether the stressors that are associated with HF activate the
cortisol system and contribute to the onset or exacerbation of
certain health outcomes.
Although there is evidence suggesting a relationship
between stress and poor outcomes in cardiac patients without
HF, the overall picture presented by the literature is one of
conflicting findings.60 Stress, variably defined as psychological, psychosocial, and mental stress, has been shown to
predict mortality and morbidity in patients with cardiovascular diseases.61–63 Others, with large sample sizes, have found
no association between stress level and increased admission
rates related to cardiovascular disease.64 In fact, some of
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Figure 1. Event-free survival according to salivary cortisol level.
Table 6. Adjusted Cox proportional hazards regression model
of variables associated with cardiac event-free survival (salivary
cortisol model).
Predictor variables

Hazard
ratio

Age
1.01
Female gender
0.64
NYHA class III/IV
0.74
compared to I/II
High cortisol level
2.03
compared to low level
Overall model (χ2 = 5.34, df = 4; p = 0.25)

95% CI

p

0.97–1.04
0.27–1.52
0.33–1.65

0.69
0.31
0.50

0.84–4.927

0.12

CI: confidence interval; NYHA: New York Heart Association.

these investigators demonstrated an inverse relationship
between stress and all-cause mortality, as well as cardiac
mortality.64 Other investigators have demonstrated a difference between men and women in the prediction of mortality
by stress in hospitalized medical patients.50,51 Stress in male
patients predicted all-cause mortality; however, no association was found between stress and mortality among
women.65,66 Investigators explained those results by stating
that men are more vulnerable to stress than women. In addition, they expressed concerns that use of the two-question
short version of the perceived stress scale did not capture
some aspects of the stress phenomena.65,66
Our neutral finding about the relationship between stress
and outcomes may be related to our small sample size, yet
other investigators with very large sample sizes have similarly
failed to find an association.64 Although patients in our sample
had a higher stress level compared to other populations,39,51

the average score on the stress instrument was only moderately high. Thus, it may be that patients in this sample did not
experience a stress level high enough to demonstrate the
hypothesized relationship. Another potential explanation for
our finding is that the instrument did not adequately capture
stress. We used the 4-item perceived stress scale, which has
been demonstrated to be valid and reliable; nonetheless, the
full instrument may have provided more complete information about stress level than the short version.39,51,67 The
6-month follow-up period may have been too short to capture
the effect of stress on the health outcomes in patients with HF.
Another possible explanation is that there is no relationship
between stress level and outcomes in patients with HF. This
explanation is supported by the number of investigations in
which no relationship has been found in patients with a variety
of health conditions.64,68,69 A final possible explanation is that
there is an indirect association of stress with outcomes that is
mediated through another construct such as coping.
We found no association between stress level and salivary
cortisol level. Our findings are consistent with a study of
breast cancer patients that showed no significant relationship
between stress and salivary cortisol level.70 Our study was
similar to this study of breast cancer patients in that medically ill individuals with conditions that may be stressful
were studied. In a literature review71 designed to evaluate
salivary cortisol as a biomarker of self-reported mental stress
in field studies of healthy adults, the authors examined 14
studies published in medium or high quality journals. Results
from eight studies demonstrated no association between selfreported mental stress and cortisol response: in four studies,
there was a positive association, and in two studies a negative association.71 They concluded that in healthy adults,
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there were insufficient data to support a relationship and postulated that the association, if present, might only be evident
in those with extremely high levels of stress. There are no
other reviews more relevant to our sample of HF patients,
but the suggestion that patients may need to experience very
high levels of stress for the association to become evident is
valid to our sample.
Our finding showed an association between salivary cortisol level and all-cause mortality in patients with HF in the
unadjusted model which is consistent with those of Yamaji
et al.72 who found that serum cortisol levels were a predictor
of cardiac events patients with chronic HF. However, in the
adjusted model, that association was no longer significant.
Similarly, others have found no such relationship between
cortisol and acute coronary events among patients with acute
coronary syndrome.73 The investigators relate their negative
results to the interruption in cortisol rhythms during hospitalization, and this explanation may be relevant to our
sample.

Study strengths and limitations
Strengths of our study include use of valid and reliable
instruments to measure stress, salivary cortisol, and other
covariates. Furthermore, we investigated multiple associations in this study that will form a foundation for future
research in the field who are interested in stress and its effect
on health outcomes in patients with HF.
The sample size of our study was a limitation that may
have hindered our ability to demonstrate potential associations. As previously noted, however, a failure to find these
associations has been noted in several studies with much
larger sample sizes. The use of the 4-item perceived stress
scale may limit the amount of information that we are able
to collect related to stress; however, we used strict protocols and reliable and valid instruments for patients with
HF.47,74–76

Conclusion
Our findings suggest that there is no relationship between
stress level, as measured using the 4-item Perceived Stress
Scale, and cardiac rehospitalization and all-cause death in
patients with HF. Our findings also suggest that in the setting
of HF, a condition that produces high levels of background
physiological stress, there is no association between selfreported stress and salivary cortisol. Before these findings
can be accepted, future studies among HF patients with
higher levels of stress and in larger sample sizes must be
conducted.
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